Invasive cervical cancer following treatment of pre-invasive lesions: A potential theory based on a small case series



      The aim of this study is to present a single department’s experience on cervical cancer cases following previous excision of cervical intraepithelial neoplasia (CIN) and to discuss potential pathogenesis.


      Nine cervical cancer cases meeting the inclusion criteria, with available pathological and follow-up data, were considered eligible for this study.


      The majority (7/9) have had clear excisional margins. The interval between initial treatment and cancer diagnosis ranged from 7 to 17 years. In all cases cancer diagnosis was “unexpected”, as the prior cytological and/or colposcopic evaluation was not suggestive of significant cervical pathology. All cancers were squamous, and 5/9 at stage I.


      The long interval between initial CIN treatment and final diagnosis as well as the normal post-treatment follow-up may suggest a ‘de novo’ underlying but ‘hidden’ carcinogenesis process. It might be that dysplastic cells entrapped within crypts (or normal metaplastic affected by the same predisposing factors) continue undergoing their evolution, undetectable by cytology and colposcopy until they invade stroma and surfaces (endo- and/or ectocervical) approximately a decade later. Heavy cauterisation of cervical crater produced post excision might be a potential culprit of this entrapment.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


        • Soutter W.P.
        • de Barros Lopes A.
        • Fletcher A.
        • Monaghan J.M.
        • Duncan I.D.
        • Paraskevaidis E.
        • et al.
        Invasive cervical cancer after conservative therapy for cervical intraepithelial neoplasia.
        Lancet. 1997; 349: 978-980
        • Evans H.S.
        • Newnham A.
        • Hodgson S.V.
        • Møller H.
        Second primary cancers after cervical intraepithelial neoplasia III and invasive cervical cancer in Southeast England.
        Gynecol Oncol. 2003; 90: 131-136
        • Kalliala I.
        • Anttila A.
        • Pukkala E.
        • Nieminen P.
        Risk of cervical and other cancers after treatment of cervical intraepithelial neoplasia: retrospective cohort study.
        BMJ. 2005; 331: 1183-1185
        • Strander B.
        • Andersson-Ellström A.
        • Milsom I.
        • Sparén P.
        Long term risk of invasive cancer after treatment for cervical intraepithelial neoplasia grade 3: population based cohort study.
        BMJ. 2007; 335: 1077
        • Melnikow J.
        • McGahan C.
        • Sawaya G.F.
        • Ehlen T.
        • Coldman A.
        Cervical intraepithelial neoplasia outcomes after treatment: long-term follow-up from the British Columbia Cohort Study.
        J Natl Cancer Inst. 2009; 101: 721-728
      1. McCredie MR, Paul C, Sharples KJ, Baranyai J, Medley G, Skegg DC, et al. Consequences in women of participating in a study of the natural history of cervical intraepithelial neoplasia 3. Aust N Z J Obstet Gynaecol. 2010;50:363-70.

        • Jakobsson M.
        • Pukkala E.
        • Paavonen J.
        • Tapper A.-M.
        • Gissler M.
        Cancer incidence among Finnish women with surgical treatment for cervical intraepithelial neoplasia, 1987–2006.
        Int J Cancer. 2011; 128: 1187-1191
        • Rapiti E.
        • Usel M.
        • Neyroud-Caspar I.
        • Merglen A.
        • Verkooijen H.M.
        • Vlastos A.T.
        • et al.
        Omission of excisional therapy is associated with an increased risk of invasive cervical cancer after cervical intraepithelial neoplasia III.
        Eur J Cancer. 2012; 48: 845-852
      2. Rebolj M, Helmerhorst T, Habbema D, Looman C, Boer R, van Rosmalen J, et al. Risk of cervical cancer after completed post-treatment follow-up of cervical intraepithelial neoplasia: population based cohort study. BMJ. 2012;345:e6855.

        • Kalliala I.
        • Athanasiou A.
        • Veroniki A.A.
        • Salanti G.
        • Efthimiou O.
        • Raftis N.
        • et al.
        Incidence and mortality from cervical cancer and other malignancies after treatment of cervical intraepithelial neoplasia: a systematic review and meta-analysis of the literature.
        Ann Oncol. 2020; 31: 213-227
      3. Loopik DL, IntHout J, Ebisch RMF, Melchers WJG, Massuger LFAG, Siebers AG, et al. The risk of cervical cancer after cervical intraepithelial neoplasia grade 3: A population-based cohort study with 80,442 women. Gynecol Oncol. 2020:S0090-8258(20)30067-6.

      4. Massad LS, Einstein MH, Huh WK, Katki HA, Kinney WK, Schiffman M, et al. 2012 updated consensus guidelines for the management of abnormal cervical cancer screening tests and cancer precursors. J Low Genit Tract Dis. 2013;17:S1-S27.

        • Kocken M.
        • Helmerhorst T.J.M.
        • Berkhof J.
        • Louwers J.A.
        • Nobbenhuis M.AE.
        • Bais A.G.
        • et al.
        Risk of recurrent high-grade cervical intraepithelial neoplasia after successful treatment: a long-term multi-cohort study.
        Lancet Oncol. 2011; 12: 441-450
        • Paraskevaidis E.
        • Jandial L.
        • Mann E.M.
        • Fisher P.M.
        • Kitchener H.C.
        Pattern of treatment failure following laser for cervical intraepithelial neoplasia: implications for follow-up protocol.
        Obstet Gynecol. 1991; 78: 80-83
        • Ault K.A.
        Epidemiology and natural history of human papillomavirus infections in the female genital tract.
        Infect Dis Obstet Gynecol. 2006; 2006: 1-5
        • Gravitt P.E.
        The known unknowns of HPV natural history.
        J Clin Invest. 2011; 121: 4593-4599
        • Athanasiou A.
        • Veroniki A.A.
        • Efthimiou O.
        • Kalliala I.
        • Naci H.
        • Bowden S.
        • et al.
        Comparative efficacy and complication rates after local treatment for cervical intraepithelial neoplasia and stage 1a1 cervical cancer: protocol for a systematic review and network meta-analysis from the CIRCLE Group.
        BMJ Open. 2019; 9: e028008
        • Athanasiou A.
        • Veroniki A.A.
        • Efthimiou O.
        • Kalliala I.
        • Naci H.
        • Bowden S.
        • et al.
        Comparative fertility and pregnancy outcomes after local treatment for cervical intraepithelial neoplasia and stage 1a1 cervical cancer: protocol for a systematic review and network meta-analysis from the CIRCLE group.
        BMJ Open. 2019; 9: e028009
      5. Ang C, Mukhopadhyay A, Burnley C, Faulkner K, Cross P, Martin-Hirsch P, et al. Histological recurrence and depth of loop treatment of the cervix in women of reproductive age: incomplete excision versus adverse pregnancy outcome. Bjog. 2011;118:685-92.

        • Paraskevaidis E.
        • Lolis E.D.
        • Koliopoulos G.
        • Alamanos Y.
        • Fotiou S.
        • Kitchener H.C.
        Cervical intraepithelial neoplasia outcomes after large loop excision with clear margins.
        Obstet Gynecol. 2000; 95: 828-831
      6. Public_Health_England. Colposcopic diagnosis, treatment and follow up. 2020.

        • Paraskevaidis Evangelos
        • Arbyn Marc
        • Sotiriadis Alexandros
        • Diakomanolis Emmanuel
        • Martin-Hirsch Pierre
        • Koliopoulos George
        • et al.
        The role of HPV DNA testing in the follow-up period after treatment for CIN: a systematic review of the literature.
        Cancer Treat Rev. 2004; 30: 205-211
        • Heinonen Annu
        • Jakobsson Maija
        • Kiviharju Mari
        • Virtanen Seppo
        • Aro Karoliina
        • Kyrgiou Maria
        • et al.
        Role of Colposcopy after Treatment for Cervical Intraepithelial Neoplasia.
        Cancers (Basel). 2020; 12: 1683
        • Perkins Rebecca B.
        • Guido Richard S.
        • Castle Philip E.
        • Chelmow David
        • Einstein Mark H.
        • Garcia Francisco
        • et al.
        2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors.
        J Low Genit Tract Dis. 2020; 24: 102-131
      7. Finnish_Medical_Society_Duodecim. Current Care Guidelines. Cytological Changes in the Cervix, Vagina and Vulva. Current Care Guidelines. Working Group Set Up by the Finnish Medical Society Duodecim and the Finnish Cardiac Society. 2021.